BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ganesan A, Barakat K. Applications of computer-aided approaches in the development of hepatitis C antiviral agents. Expert Opin Drug Discov 2017;12:407-25. [PMID: 28164720 DOI: 10.1080/17460441.2017.1291628] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
Number Citing Articles
1 Elfiky AA. Novel guanosine derivatives against Zika virus polymerase in silico. J Med Virol 2020;92:11-6. [PMID: 31436327 DOI: 10.1002/jmv.25573] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
2 Rofeal M, El-Malek FA. Ribosomal proteins as a possible tool for blocking SARS-COV 2 virus replication for a potential prospective treatment. Med Hypotheses 2020;143:109904. [PMID: 32502901 DOI: 10.1016/j.mehy.2020.109904] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Gawriljuk VO, Foil DH, Puhl AC, Zorn KM, Lane TR, Riabova O, Makarov V, Godoy AS, Oliva G, Ekins S. Development of Machine Learning Models and the Discovery of a New Antiviral Compound against Yellow Fever Virus. J Chem Inf Model 2021;61:3804-13. [PMID: 34286575 DOI: 10.1021/acs.jcim.1c00460] [Reference Citation Analysis]
4 Elfiky AA. Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sci. 2020;253:117592. [PMID: 32222463 DOI: 10.1016/j.lfs.2020.117592] [Cited by in Crossref: 371] [Cited by in F6Publishing: 342] [Article Influence: 185.5] [Reference Citation Analysis]
5 Elfiky AA, Mahran HA, Ibrahim IM, Ibrahim MN, Elshemey WM. Molecular dynamics simulations and MM-GBSA reveal novel guanosine derivatives against SARS-CoV-2 RNA dependent RNA polymerase. RSC Adv 2022;12:2741-50. [DOI: 10.1039/d1ra07447d] [Reference Citation Analysis]
6 Mirza MU, Vanmeert M, Froeyen M, Ali A, Rafique S, Idrees M. In silico structural elucidation of RNA-dependent RNA polymerase towards the identification of potential Crimean-Congo Hemorrhagic Fever Virus inhibitors. Sci Rep 2019;9:6809. [PMID: 31048746 DOI: 10.1038/s41598-019-43129-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
7 Elfiky AA, Ismail AM. Molecular modeling and docking revealed superiority of IDX-184 as HCV polymerase inhibitor. Future Virology 2017;12:339-47. [DOI: 10.2217/fvl-2017-0027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
8 Elfiky AA, Azzam EB. Novel guanosine derivatives against MERS CoV polymerase: An in silico perspective. J Biomol Struct Dyn 2021;39:2923-31. [PMID: 32306854 DOI: 10.1080/07391102.2020.1758789] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 12.5] [Reference Citation Analysis]
9 Rajendran M, Roy S, Ravichandran K, Mishra B, Gupta DK, Nagarajan S, Arul Selvaraj RC, Provaznik I. In silico screening and molecular dynamics of phytochemicals from Indian cuisine against SARS-CoV-2 MPro. J Biomol Struct Dyn 2020;:1-15. [PMID: 33200680 DOI: 10.1080/07391102.2020.1845980] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Ahmad Mir S, Firoz A, Alaidarous M, Alshehri B, Aziz Bin Dukhyil A, Banawas S, Alsagaby SA, Alturaiki W, Ahmad Bhat G, Kashoo F, Abdel-Hadi AM. Identification of SARS-CoV-2 RNA-dependent RNA polymerase inhibitors from the major phytochemicals of Nigella sativa: An in silico approach. Saudi J Biol Sci 2021. [PMID: 34518755 DOI: 10.1016/j.sjbs.2021.09.002] [Reference Citation Analysis]
11 Bitencourt-ferreira G, de Azevedo WF. Molegro Virtual Docker for Docking. In: de Azevedo WF, editor. Docking Screens for Drug Discovery. New York: Springer; 2019. pp. 149-67. [DOI: 10.1007/978-1-4939-9752-7_10] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 5.7] [Reference Citation Analysis]
12 Gorgulla C, Fackeldey K, Wagner G, Arthanari H. Accounting of Receptor Flexibility in Ultra-Large Virtual Screens with VirtualFlow Using a Grey Wolf Optimization Method. Supercomput Front Innov 2020;7:4-12. [PMID: 34693068 DOI: 10.14529/jsfi200301] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Singh S, Sk MF, Sonawane A, Kar P, Sadhukhan S. Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 via RNA-dependent RNA polymerase (RdRp) inhibition: an in-silico analysis. J Biomol Struct Dyn 2020;:1-16. [PMID: 32720577 DOI: 10.1080/07391102.2020.1796810] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 12.0] [Reference Citation Analysis]
14 Pal A, Curtin JF, Kinsella GK. In silico and in vitro screening for potential anticancer candidates targeting GPR120. Bioorg Med Chem Lett 2021;31:127672. [PMID: 33161126 DOI: 10.1016/j.bmcl.2020.127672] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Elfiky AA, Elshemey WM. Molecular dynamics simulation revealed binding of nucleotide inhibitors to ZIKV polymerase over 444 nanoseconds. J Med Virol 2018;90:13-8. [PMID: 28922464 DOI: 10.1002/jmv.24934] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
16 Liu C, Yin J, Yao J, Xu Z, Tao Y, Zhang H. Pharmacophore-Based Virtual Screening Toward the Discovery of Novel Anti-echinococcal Compounds. Front Cell Infect Microbiol 2020;10:118. [PMID: 32266168 DOI: 10.3389/fcimb.2020.00118] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
17 Elfiky AA. Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sci. 2020;248:117477. [PMID: 32119961 DOI: 10.1016/j.lfs.2020.117477] [Cited by in Crossref: 305] [Cited by in F6Publishing: 290] [Article Influence: 152.5] [Reference Citation Analysis]
18 Ismail AM, Elfiky AA, Elshemey WM. Recognition of the gluconeogenic enzyme, Pck1, via the Gid4 E3 ligase: An in silico perspective. J Mol Recognit 2019;33. [DOI: 10.1002/jmr.2821] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Nimgampalle M, Devanathan V, Saxena A. Screening of Chloroquine, Hydroxychloroquine and its derivatives for their binding affinity to multiple SARS-CoV-2 protein drug targets. J Biomol Struct Dyn 2021;39:4949-61. [PMID: 32579059 DOI: 10.1080/07391102.2020.1782265] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
20 Iftikhar H, Ali HN, Farooq S, Naveed H, Shahzad-Ul-Hussan S. Identification of potential inhibitors of three key enzymes of SARS-CoV2 using computational approach. Comput Biol Med 2020;122:103848. [PMID: 32658735 DOI: 10.1016/j.compbiomed.2020.103848] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
21 Pandey K, Lokhande KB, Swamy KV, Nagar S, Dake M. In Silico Exploration of Phytoconstituents From Phyllanthus emblica and Aegle marmelos as Potential Therapeutics Against SARS-CoV-2 RdRp. Bioinform Biol Insights 2021;15:11779322211027403. [PMID: 34248355 DOI: 10.1177/11779322211027403] [Reference Citation Analysis]
22 Romeo I, Marascio N, Pavia G, Talarico C, Costa G, Alcaro S, Artese A, Torti C, Liberto MC, Focà A. Structural Modeling of New Polymorphism Clusters of HCV Polymerase Isolated from Direct‐Acting Antiviral Naïve Patients: Focus on Dasabuvir and Setrobuvir Binding Affinity. ChemistrySelect 2018;3:6009-17. [DOI: 10.1002/slct.201800649] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
23 de Albuquerque PPLF, Santos LHS, Antunes D, Caffarena ER, Figueiredo AS. Structural insights into NS5B protein of novel equine hepaciviruses and pegiviruses complexed with polymerase inhibitors. Virus Res 2020;278:197867. [PMID: 31972246 DOI: 10.1016/j.virusres.2020.197867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
24 Li J, Boix E. Host Defence RNases as Antiviral Agents against Enveloped Single Stranded RNA Viruses. Virulence 2021;12:444-69. [PMID: 33660566 DOI: 10.1080/21505594.2021.1871823] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
25 Wagner JR, Churas CP, Liu S, Swift RV, Chiu M, Shao C, Feher VA, Burley SK, Gilson MK, Amaro RE. Continuous Evaluation of Ligand Protein Predictions: A Weekly Community Challenge for Drug Docking. Structure 2019;27:1326-1335.e4. [PMID: 31257108 DOI: 10.1016/j.str.2019.05.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
26 Jindal G, Mondal D, Warshel A. Exploring the Drug Resistance of HCV Protease. J Phys Chem B 2017;121:6831-40. [PMID: 28635289 DOI: 10.1021/acs.jpcb.7b04562] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
27 Elfiky AA. SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective. J Biomol Struct Dyn 2021;39:3204-12. [PMID: 32338164 DOI: 10.1080/07391102.2020.1761882] [Cited by in Crossref: 70] [Cited by in F6Publishing: 89] [Article Influence: 35.0] [Reference Citation Analysis]
28 Abu-Melha S, Edrees MM, Riyadh SM, Abdelaziz MR, Elfiky AA, Gomha SM. Clean Grinding Technique: A Facile Synthesis and In Silico Antiviral Activity of Hydrazones, Pyrazoles, and Pyrazines Bearing Thiazole Moiety against SARS-CoV-2 Main Protease (Mpro). Molecules 2020;25:E4565. [PMID: 33036293 DOI: 10.3390/molecules25194565] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
29 Singh SK, Upadhyay AK, Reddy MS. Screening of potent drug inhibitors against SARS-CoV-2 RNA polymerase: an in silico approach. 3 Biotech 2021;11:93. [PMID: 33520579 DOI: 10.1007/s13205-020-02610-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Elfiky AA, Ismail AM. Molecular docking revealed the binding of nucleotide/side inhibitors to Zika viral polymerase solved structures. SAR QSAR Environ Res 2018;29:409-18. [PMID: 29652194 DOI: 10.1080/1062936X.2018.1454981] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
31 Sinigaglia A, Riccetti S, Trevisan M, Barzon L. In silico approaches to Zika virus drug discovery. Expert Opin Drug Discov 2018;13:825-35. [PMID: 30160181 DOI: 10.1080/17460441.2018.1515909] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]